Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PDEX: Triple Therapy vs Ranibizumab in AMD
NCT00390208Phase 2Completed
- Sponsor
- Bay Area Retina Associates
- Start
- Aug 2006
- Primary completion
- Dec 2008
- Modality
- Antibody Fragments, Antibody Conjugates, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ranibizumab, dexamethasone, verteporfin in age-related macular degeneration (AMD), sponsored by Bay Area Retina Associates. Started Aug 2006; status: completed.
02
Drugs
ranibizumabdexamethasoneverteporfin
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT00390208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00390208.